Abraxas Petroleum Corp (AXAS) 4.19 $AXAS The Zacks

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Abraxas Petroleum Corp (AXAS) 4.19 $AXAS

The Zacks Analyst Blog Highlights: Chevron, Exxon Mobil, Range Resources, Abraxas Petroleum and Boeing.
PR Newswire - Mon Apr 07, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Chevron Corp. (NYSE:CVX-Free Report), Exxon Mobil Corp. (NYSE:XOM-Free Report), Range Resources Corp. (NYSE:RRC-Free Report), Abraxas Petroleum Corp. (Nasdaq:AXAS-Free Report) and Boeing Company (NYSE:BA-Free Report).

Chevron: Core Holding in the Integrated Space - Analyst Blog
Nilanjan Choudhury - Zacks Investment Research - Fri Apr 04, 3:06PM CDT
We continue to view San Ramon, Calif.-based energy giant Chevron Corp.as a core holding in the large-cap integrated space.

Ultra Petroleum Makes the Right Moves to Hit 52-Week High (Revised) - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 9:10AM CDT
Shares of natural gas producer Ultra Petroleum Corp. hit a 52-week high of $28.76 on Apr 3

Anadarko Petroleum (APC) Surges: Stock Adds 14.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 7:37AM CDT
Anadarko Petroleum Corporation was a big mover last session, as the company saw its shares rise nearly 15% on the day.

Abraxas Provides Operational and Divestiture Update; Announces Upcoming Presentation
Business Wire - Thu Apr 03, 4:34PM CDT
Abraxas Petroleum Corporation (NASDAQ:AXAS) is pleased to provide the following operational and divestiture update and announce an upcoming presentation.

Ultra Petroleum Makes the Right Moves to Hit 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 02, 3:20PM CDT
Shares of energy explorer Ultra Petroleum Corp. hit a 52-week high of $27.26 on Mar 28, as the company focuses on profit growth.

Why Abraxas Petroluem (AXAS) Shares Are Falling
at The Street - Thu Mar 27, 11:09AM CDT
Shares of Abraxas Petroleum (AXAS) are falling following a downgrade to 'hold' from 'buy' by Canaccord.

Investors look to Lighten Up on Shares of Abraxas Petroleum, Shares Down 7.1% (AXAS)
Comtex SmarTrend(R) - Thu Mar 27, 10:40AM CDT
Abraxas Petroleum (NASDAQ:AXAS) is one of today's worst performing low-priced stocks, down 7.1% to $3.68 on 1.4x average daily volume. Thus far today, Abraxas Petroleum has traded 1.8 million shares, vs. average volume of 1.3 million shares per day. The stock has underperformed the Dow (-7.0% to the Dow's 0.0%) and underperformed the S&P 500 (-7.0% to the S&P's -0.1%) during today's trading.

Downgrade Alert for Abraxas Petroleum (AXAS)
Comtex SmarTrend(R) - Wed Mar 26, 7:00AM CDT
Abraxas Petroleum (NASDAQ:AXAS) was downgraded from Buy to Hold at Canaccord Genuity today. The stock closed yesterday at $4.09 on volume of 1.2 million shares, below average daily volume of 1.3 million. In the past 52 weeks, Abraxas Petroleum share prices have been bracketed by a low of $1.99 and a high of $4.15 and closed yesterday at $4.09, 106% above that low price. The 200-day and 50-day moving averages have moved 0.90% higher and 1.63% higher over the past week, respectively.

Coverage of Top Gainers -- Research on Synta Pharma, BG Medicine, Abraxas Petroleum, and xG Technology
PR Newswire - Wed Mar 19, 7:25AM CDT
The US markets saw a positive sentiment on Tuesday, March 18, 2014, with the NASDAQ Composite closing at 4,333.31, up 1.25%, the Dow Jones Industrial Average ending the session at 16,336.19, up 0.55% and the S&P 500 edging 0.72% higher to finish the trading session at 1,872.25. During the session, gains in the Information Technology, Health Care, and Energy sectors positively impacted the broader market. A number of stocks saw large movements, including Synta Pharmaceuticals Corp. (NASDAQ: SNTA), BG Medicine Inc. (NASDAQ: BGMD), Abraxas Petroleum Corp. (NASDAQ: AXAS), and xG Technology Inc. (NASDAQ: XGTI). Free technical research on SNTA, BGMD, AXAS and XGTI can be downloaded upon signing up at:

Abraxas Petroleum Up 6.0%, Shares Break Through Resistance (AXAS)
Comtex SmarTrend(R) - Tue Mar 18, 10:41AM CDT
Abraxas Petroleum (NASDAQ:AXAS) is one of today's best performing low-priced stocks, up 6.0% to $3.88 on 1.3x average daily volume. Abraxas Petroleum has traded 1.2 million shares thus far today, vs. average volume of 976,000 shares per day. The stock has outperformed the Dow (6.0% to the Dow's 0.6%) and outperformed the S&P 500 (6.0% to the S&P's 0.6%) during today's trading.

Why Abraxas Petroleum (AXAS) Could Be a Potential Winner - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 7:38AM CDT
Abraxas Petroleum has seen small price movement but large earnings estimate revisions, making it an unappreciated stock that might have potential for gains

Balanced Prospects at Anadarko Petroleum - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 17, 12:39PM CDT
On Mar 13, we issued an updated research report on Anadarko Petroleum Corporation.

Abraxas (AXAS) Worth Watching: Stock Moves 6.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 8:46AM CDT
Abraxas was a big mover last session, with shares rising nearly 7% on the day.

Upgrade Alert for Abraxas Petroleum (AXAS)
Comtex SmarTrend(R) - Thu Mar 13, 8:07AM CDT
Abraxas Petroleum (NASDAQ:AXAS) was upgraded from Neutral to Accumulate at Global Hunter today. The stock closed yesterday at $3.14 on volume of 1.1 million shares, above average daily volume of 900,000. Potential upside of 33.4% exists for Abraxas Petroleum, based on a current level of $3.14 and analysts' average consensus price target of $4.19. The stock should find resistance at its 50-day moving average (MA) of $3.24, as well as support at its 200-day MA of $2.87.

Abraxas Announces 2013 Results
Business Wire - Wed Mar 12, 5:00AM CDT
Abraxas Petroleum Corporation (NASDAQ:AXAS) today reported financial and operating results for the three and twelve months ended December 31, 2013.

Abraxas Provides Operational Update, Divestiture and Guidance Update
Business Wire - Wed Mar 12, 5:00AM CDT
Abraxas Petroleum Corporation (NASDAQ:AXAS) is pleased to provide the following operational, divestiture and guidance update.

Atlas Resource Partners Wraps Up Unit Offering - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 12:10PM CDT
On Mar 7, 2014, Atlas Resource Partners LP declared the closure of the earlier announced common units offering.

Warren Resources Beats on Q4 Earnings, Reserves Grow - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 9:10AM CDT
On Mar 6, 2014, Warren Resources Inc. reported strong fourth-quarter 2013 earnings, on the back of lower operating expenses and increased crude oil production.

Constellation Energy Slumps: CEP Falls 6.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 7:54AM CST
Constellation Energy saw a big move last session on pretty good volume with far more shares changing hands than in a normal session; shares fell over 6% on the day.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BioVid Debuts AI to Mimic Physician Decision-Making

Updated Category News Views 47

Revolutionizing Understanding: BioVid Mimetics™ Now here's something that's shaking the research tree: BioVid's launching Mimetics™, and it's a big deal. They've come up with AI that can mirror how physicians think and decide. This ain't your run-of-the-mill tech stuff—it's groundbreaking in understanding physician decision-making. The Core: How Do Doctors Really...

Continue Reading
Acqualina Resort's Sustainable Commitment Earns Praise

Updated Category News Views 52

Sustainability at the Heart of Luxury Spotlight's on Acqualina Resort again. The folks there have snagged the 2026 VERIFIED™ Responsible Hospitality badge from Forbes Travel Guide for the third straight year. Means they’re more than just a pretty face down in Miami. This accolade puts them slap bang among the best in sustainable luxury. Forbes doesn’t just hand...

Continue Reading
Divorce Expertise: Obenhaus Adds CDFA Credential

Updated Category News Views 84

Divorce isn't just a legal tangled mess; it's a financial minefield as well. Lindsey Obenhaus from Goranson Bain Ausley has beefed up her credentials with a Certified Divorce Financial Analyst® (CDFA®) designation, lending a sharper edge to her approach in divorce financials. When relationships turn sour, so do wallets, and Obenhaus aims to soften that blow for her...

Continue Reading
Howard Hughes Joins S&P SmallCap 600, Arcosa Out

Updated Category News Views 45

Shakeup in the S&P SmallCap 600 It’s one of those days where something shifts in the market landscape—Howard Hughes Holdings Inc. (NYSE: HHH) is swaggering into the S&P SmallCap 600. Kicking off on October 28, it's got quite the entrance lined up. On the other end, Arcosa Inc. (NYSE: ACA) is making a hasty exit after getting scooped up by CRH plc (NYSE: CRH). For...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 15

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Amy Johnson Steps Up as GDIT President Amid Shifts

Updated Category News Views 68

A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 40

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Think Together Marks 20 Years of ASES Impact in CA

Updated Category News Views 64

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

Continue Reading
University of Phoenix Unveils Credit for Prior Learning Advantages

Updated Category News Views 27

Navigating College Credits with Life Experience If you think school is the only place to pick up education that counts, think again. University of Phoenix is challenging this by recognizing the value of the hustle and grind working adults go through. During the recently wrapped-up National Transfer Student Week, Devin Andrews, their VP of Admissions and Evaluation, shed...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 142

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading

Top 5 Most Recently Viewed Articles

VERSES AI Secures Major Contract with Global Investment Firm

Updated Category News Views 183

Strategic Move by VERSES AI VERSES AI Inc. has made an impressive leap in the cognitive computing sector by securing a contract with a leading global investment firm. This partnership is rooted in the recent success of the company's Genius beta program, where initial evaluations highlighted the platform's remarkable capabilities. Enterprise Agreement Details As part of...

Continue Reading
Expected Growth of Agricultural Adjuvants Market to USD 6.2B

Updated Category News Views 143

The Agricultural Adjuvants Market: An Overview The Agricultural Adjuvants Market is witnessing remarkable growth as demand for crop protection products increases. Recent studies estimate that the market, valued at around USD 3.9 billion, is projected to reach approximately USD 6.2 billion by 2034. This translates to a compound annual growth rate (CAGR) of about 4.78% from...

Continue Reading
Understanding CVS Health Inc.'s P/E Ratio in Depth

Updated Category News Views 428

Analyzing the Price-to-Earnings Ratio of CVS Health Inc. In the current trading session, CVS Health Inc. (NYSE: CVS) is trading at a price of $79.86, experiencing a slight decrease of 0.01%. Over the past month, the stock has shown a decline of about 0.99%. However, looking back over the last year, the company's stock has seen a remarkable increase of 44.98%. This...

Continue Reading
Lead the Charge: Edwards Lifesciences Shareholders Unite

Updated Category News Views 138

Understanding the Class Action for Edwards Lifesciences Investors If you are an investor in Edwards Lifesciences Corporation (NYSE: EW), it is crucial to be aware of your rights and options, especially in the wake of substantial losses. Recent developments have opened the door for investors to come together and pursue a collective legal approach toward holding the company...

Continue Reading
Johnson Fistel Investigates Centuri's Stock Price Decline

Updated Category News Views 46

Investigating Centuri Holdings, Inc. Johnson Fistel, LLP, a well-regarded shareholder rights law firm, has initiated an investigation into Centuri Holdings, Inc. (NYSE: CTRI) following a noteworthy decline in the company’s stock price. The firm is examining whether there were any violations of securities laws by the company's executives who may have misrepresented or...

Continue Reading